发明申请
US20070265312A1 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
失效
2-N {5 - [[4- [2-（甲基-2-吡啶基氨基）乙氧基]苯基]甲基] -2,4-噻唑烷二酮}丁二酸，制备方法和马来酸罗格列酮组合物
![2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate](/docs/US/2007-11-15/US20070265312A1/abs.jpg.600x600.jpg)
- 专利标题： 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
- 专利标题（中）： 2-N {5 - [[4- [2-（甲基-2-吡啶基氨基）乙氧基]苯基]甲基] -2,4-噻唑烷二酮}丁二酸，制备方法和马来酸罗格列酮组合物
-
申请号： US11430582申请日： 2006-05-09
-
公开(公告)号： US20070265312A1公开(公告)日： 2007-11-15
- 发明人: Yehudit Dolitzky , Yoseph Avezov , Dina Spivak , Minutza Leibovici , Ben-Zion Solomon
- 申请人： Yehudit Dolitzky , Yoseph Avezov , Dina Spivak , Minutza Leibovici , Ben-Zion Solomon
- 专利权人： Teva Pharmaceutical Industries, Ltd.
- 当前专利权人： Teva Pharmaceutical Industries, Ltd.
- 主分类号： A61K31/44
- IPC分类号： A61K31/44 ; C07D417/00
![2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate](/abs-image/US/2007/11/15/US20070265312A1/abs.jpg.150x150.jpg)
摘要：
Disclosed is an isolated compound of the formula: along with methods of detecting it and of minimizing it in improved pharmaceutical compositions of rosiglitazone maleate.
公开/授权文献
信息查询
